Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1981 Aug;18(4):266–270. doi: 10.1136/jmg.18.4.266

Effectiveness of one tube osmotic fragility screening in detecting beta-thalassaemia trait.

C Kattamis, G Efremov, S Pootrakul
PMCID: PMC1048730  PMID: 7277419

Abstract

The effectiveness of the one tube method of osmotic fragility with three buffered solutions (0.32% saline, 0.36% saline, and tyrode) as a screening test for beta-thalassaemia trait was evaluated in several groups of subjects from Greece, Yugoslavia, and Thailand. The results clearly demonstrated that 0.36% saline is the most sensitive and effective solution since it could detect 96 to 100% of heterozygotes with beta-thalassaemia, compared to about 80% with both 0.32% saline and tyrode. However, 0.36% saline gave false positive results in normal subjects and was also positive in haematological disorders which influence osmotic fragility. The screening test with 0.36% saline was applied more precisely in 1371 subjects. The test was false positive in 41 (9.1%) of 455 normal subjects while of 438 confirmed heterozygotes with beta-thalassaemia it was positive in 431 (98%) and negative in only seven (2%). The test was also found to be positive in 80% of patients with iron deficiency anaemia and alpha-thalassaemia trait, in 68% of patients with Hb E trait, in 40% of patients with Hb S trait, and in 78% of heterozygotes with rare haemoglobin variants. The increased sensitivity and effectiveness of 0.36% saline in detecting beta-thalassaemia trait and other disorders influencing osmotic fragility as compared to 0.32% saline and tyrode solutions was also confirmed in a study of 384 unselected schoolchildren.

Full text

PDF
266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cao A., Galanello R., Furbetta M., Muroni P. P., Garbato L., Rosatelli C., Scalas M. T., Addis M., Ruggeri R., Maccioni L. Thalassaemia types and their incidence in Sardinia. J Med Genet. 1978 Dec;15(6):443–447. doi: 10.1136/jmg.15.6.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Efremov C. D., Huisman T. H., Bowman K., Wrightstone R. N., Shroeder W. A. Microchromatography of hemoglobins. II. A rapid method for the determination of hemoglobin A2. J Lab Clin Med. 1974 Apr;83(4):657–664. [PubMed] [Google Scholar]
  3. Kattamis C., Metaxotou-Mavromati A., Wood W. G., Nash J. R., Weatherall D. J. The heterogeneity of normal Hb A2-beta thalassaemia in Greece. Br J Haematol. 1979 May;42(1):109–123. doi: 10.1111/j.1365-2141.1979.tb03703.x. [DOI] [PubMed] [Google Scholar]
  4. Kattamis C., Metaxotou-Mavromnati A., Konidaris C., Touliatos N., Constantsas N., Matsaniotis N. Iron deficiency in Greece. Epidemiologic and hematologic studies. J Pediatr. 1974 May;84(5):666–671. doi: 10.1016/s0022-3476(74)80007-7. [DOI] [PubMed] [Google Scholar]
  5. MALAMOS B., FESSAS P., STAMATOYANNOPOULOS G. Types of thalassaemia-trait carriers as revealed by a study of their incidence in Greece. Br J Haematol. 1962 Jan;8:5–14. doi: 10.1111/j.1365-2141.1962.tb06489.x. [DOI] [PubMed] [Google Scholar]
  6. Pearson H. A., O'Brien R. T., McIntosh S. Screening for thalassemia trait by electronic measurement of mean corpuscular volume. N Engl J Med. 1973 Feb 15;288(7):351–353. doi: 10.1056/NEJM197302152880706. [DOI] [PubMed] [Google Scholar]
  7. Pootrakul S., Sapprapa S., Wasi P., Na-Nakorn S., Suwanik R. Haemoglobin synthesis in 28 obligatory cases for alpha-thalassemia traits. Humangenetik. 1975 Sep 10;29(2):121–126. doi: 10.1007/BF00430348. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES